Founded by former SpaceX engineers, Synthego is a leading provider of genome engineering solutions. The company's flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research. Synthego's vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist. Headquartered in Silicon Valley, California, Synthego customers include leading institutions in 31 countries around the world, and 9 of the top 10 global biology universities.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/04/17 | $41,000,000 | Series B |
Alexandria Real Estate Equities AME Cloud Ventures Elements Capital Founders Fund Jamie H. Doudna Cate Jennifer Doudna Menlo Ventures OS Fund SciFi VC WI Harper Group Zhen Fund | undisclosed |
| 10/23/18 | $110,000,000 | Series C |
Founders Fund Menlo Ventures | undisclosed |
| 08/27/20 | $100,000,000 | Series D |
Founders Fund Intel Capital Menlo Ventures RA Capital Management Wellington Management Company | undisclosed |
